Headline News about Roche Holding AG Basel American Depositary Shares![]() Via Benzinga
![]() ![]() ![]() ![]() ![]()
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]()
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
January 16, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() Via Talk Markets
![]() ![]() ![]() ![]()
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]()
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
December 15, 2023
Via Benzinga
Topics
Regulatory Compliance
![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Roche Holding AG Basel American Depositary Shares (OP: RHHBY )Headline News about Roche Holding AG Basel American Depositary Shares
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|